Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011236
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism and digestive system, cardiovascular system, blood system, central nervous system drugs, anti-infection, anti-tumor, vaccine and raw material and intermediates. It provides medical diagnostic products such as real time PCR detector, human papillomavirus genotyping kit, HBV quantitative reagent, and biofosun microorganism identification and susceptibility analysis system. The company’s research and development unit concentrates on therapeutic areas of metabolism and digestive system, blood system, cardiovascular system and central nervous system. Fosun Pharma is headquartered in Shanghai, China.

Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deal Details 13
Venture Financing 13
Paragon Genomics Raises USD8 Million in Series A Financing 13
Spirometrix Raises USD17.4 Million in Series C Financing 14
Check-Cap Raises Funds through Venture Financing 15
Saladax Biomedical Raises US$23 Million In Series D Venture Financing 16
Private Equity 18
Healthy Harmony and Shanghai Fosun Pharma Acquire Chindex International in Going Private Transaction for USD461 Million 18
PBM Capital Acquires Breas Medical From GE Healthcare 20
KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 21
Partnerships 22
Intuitive Surgical to Form Joint Venture with Shanghai Fosun Pharma 22
Astute Medical Enters into Distribution Agreement with Fosun Long March 23
CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 24
Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 25
Litha Pharma Partners with Gland Pharma 26
Equity Offering 27
Shanghai Fosun Pharma to Raise USD298.3 Million in Private Placement of Shares 27
Chindex to Raise USD38.2 Million in Private Placement of Shares 29
Debt Offering 30
Shanghai Fosun Pharma Plans to Raise up to USD1 Billion in Private Placement of Bonds 30
Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 31
Acquisition 32
Shanghai Fosun Pharma to Acquire 65% Stake in SinoMedCare Biotech for USD40 Million 32
Fosun Pharma Acquires 80% stake in Breas Medical 33
Breas Medical Acquires B&D Electromedical 34
Shanghai Fosun Pharma Acquires 37% Stake in miacom diagnostics 35
Shanghai Fosun to Acquire 35% Stake in Sinopharm Holding Medical Investment Management from Sinopharm Group for up to USD32.4 Million 36
Fosun Pharma And Pramerica-Fosun China Opportunity Fund Complete Acquisition Of 95.6% Stake In Alma Lasers For US$250 Million 37
Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company 39
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Competitors 40
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Employees 41
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Joint Venture 44
Recent Developments 45
Corporate Communications 45
Jun 29, 2016: Shanghai Fosun Pharmaceutical (Group) Announces Resignation Of Non-Executive Director 45
Jun 07, 2016: Shanghai Fosun Pharmaceutical Announces Management Changes, Names New President and CEO 46
Mar 02, 2016: Resignation Of Non-Executive Director: Shanghai Fosun Pharmaceutical 48
Legal and Regulatory 49
Sep 05, 2017: Fosun Pharmas Subsidiary Sisram, the World’s Leading Energy-Based Medical Aesthetic Treatment Systems Provider, to be Listed as the First Israeli Company on the Main Board of SEHK 49
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Key Facts, 2016 2
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Deals By Market, 2011 to YTD 2017 9
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Paragon Genomics Raises USD8 Million in Series A Financing 13
Spirometrix Raises USD17.4 Million in Series C Financing 14
Check-Cap Raises Funds through Venture Financing 15
Saladax Biomedical Raises US$23 Million In Series D Venture Financing 16
Healthy Harmony and Shanghai Fosun Pharma Acquire Chindex International in Going Private Transaction for USD461 Million 18
PBM Capital Acquires Breas Medical From GE Healthcare 20
KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 21
Intuitive Surgical to Form Joint Venture with Shanghai Fosun Pharma 22
Astute Medical Enters into Distribution Agreement with Fosun Long March 23
CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 24
Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 25
Litha Pharma Partners with Gland Pharma 26
Shanghai Fosun Pharma to Raise USD298.3 Million in Private Placement of Shares 27
Chindex to Raise USD38.2 Million in Private Placement of Shares 29
Shanghai Fosun Pharma Plans to Raise up to USD1 Billion in Private Placement of Bonds 30
Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 31
Shanghai Fosun Pharma to Acquire 65% Stake in SinoMedCare Biotech for USD40 Million 32
Fosun Pharma Acquires 80% stake in Breas Medical 33
Breas Medical Acquires B&D Electromedical 34
Shanghai Fosun Pharma Acquires 37% Stake in miacom diagnostics 35
Shanghai Fosun to Acquire 35% Stake in Sinopharm Holding Medical Investment Management from Sinopharm Group for up to USD32.4 Million 36
Fosun Pharma And Pramerica-Fosun China Opportunity Fund Complete Acquisition Of 95.6% Stake In Alma Lasers For US$250 Million 37
Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company 39
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Competitors 40
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Employees 41
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Subsidiaries 43
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Joint Venture 44

★海外企業調査レポート[Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vergnet SA (ALVER):企業の財務・戦略的SWOT分析
    Vergnet SA (ALVER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Assurant, Inc.:企業の戦略・SWOT・財務情報
    Assurant, Inc. - Strategy, SWOT and Corporate Finance Report Summary Assurant, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Versantis AG-製薬・医療分野:企業M&A・提携分析
    Summary Versantis AG (Versantis), is a preclinical stage pharmaceutical company which offers new medicines and diagnostics for treating liver diseases. It’s lead pipeline product VS-01, capable of removing toxic agents from the organism and save patients from prescription and illicit drug overdoses. …
  • Trina Solar Ltd:電力:M&Aディール及び事業提携情報
    Summary Trina Solar Ltd (Trina Solar) is a vertically-integrated solar power products manufacturer. The company manufactures a wide variety of PV modules, both monocrystalline and multicrystalline; ingots, wafers, cells and solar modules. The company also designs, constructs, sells and operates sola …
  • VolitionRX Ltd (VNRX):製薬・医療:M&Aディール及び事業提携情報
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • Balaji Amines Ltd (BALAMINES)
    Balaji Amines Ltd (BALAMINES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Denizbank A.S.:企業の戦略・SWOT・財務分析
    Denizbank A.S. - Strategy, SWOT and Corporate Finance Report Summary Denizbank A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Societatea Nationala Nuclearelectrica SA (SNN)-エネルギー分野:企業M&A・提携分析
    Summary Societatea Nationala Nuclearelectrica S.A. (SNN) is a state owned power generating company. It generates nuclear power and heat using nuclear fission and also manufactures nuclear fuel. SNN is the only company producing electricity based on nuclear technology in Romania. It also produces nuc …
  • LifeTech Scientific Corporation (1302):医療機器:M&Aディール及び事業提携情報
    Summary LifeTech Scientific Corporation (LifeTech Scientific) is a manufacturer, suppler and marketer of interventional medical devices for cardiovascular diseases. The product portfolio of the company includes occluders, stent graft system, delivery system, vena cava fitter, vascular plug, sizzing …
  • Pernix Therapeutics Holdings Inc (PTX):医療機器:M&Aディール及び事業提携情報
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR …
  • Axela Inc-製薬・医療分野:企業M&A・提携分析
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • China National Petroleum Corp:電力:M&Aディール及び事業提携情報
    Summary China National Petroleum Corp (CNPC) is an integrated energy company. Its businesses cover oil and gas exploration and development, refining and chemicals, marketing and trading, pipeline transmission and stockpiling, technical services, engineering construction, equipment manufacturing, fin …
  • Fair Isaac Corp (FICO):企業の財務・戦略的SWOT分析
    Fair Isaac Corp (FICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Medigard Ltd (MGZ):医療機器:M&Aディール及び事業提携情報
    Summary Medigard Ltd (Medigard), formerly Medisafe Instruments Pty Ltd, is a medical device company that designs and develops retractable safety medical devices. The company provides products such as auto-retractable syringe, manual retractable syringe, blood collection device, intravenous valve and …
  • AIA Group Limited:企業のM&A・事業提携・投資動向
    AIA Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AIA Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Pacgen Life Science Corp (PBS):企業の財務・戦略的SWOT分析
    Summary Pacgen Life Science Corp (Pacgen), formerly Pacgen Biopharmaceuticals Corp, is a life science technology company that develops and commercializes biomedical products and services. The company offers development of novel therapeutic drug candidates. It provides product such as include amino-a …
  • BRF SA:企業の戦略・SWOT・財務分析
    BRF SA - Strategy, SWOT and Corporate Finance Report Summary BRF SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Simpson Manufacturing Co Inc (SSD):企業の財務・戦略的SWOT分析
    Simpson Manufacturing Co Inc (SSD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Storz Medical AG:企業の戦略的SWOT分析
    Storz Medical AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Ohio State University Comprehensive Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Ohio State University Comprehensive Cancer Center (OSUCCC), a subsidiary of Ohio State University, is a healthcare institute that offers medical and academic education services. The institute provides education, research, and patient care services. Its services comprise cancer diagnosis, tre …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆